Trial Profile

Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 20 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Centella asiatica extract (Primary)
Indications Diabetic foot ulcer
Focus Therapeutic Use
Acronyms TEXAS 3A, 3B
Sponsors Oneness Biotech

Most Recent Events

15 Apr 2024 Status changed from recruiting to discontinued.
13 Mar 2023 Planned number of patients changed from 12 to 8.
13 Mar 2023 Planned initiation date changed from 1 Sep 2022 to 4 Aug 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com